Literature DB >> 28507112

MCR-1 and OXA-48 In Vivo Acquisition in KPC-Producing Escherichia coli after Colistin Treatment.

Racha Beyrouthy1,2,3, Frederic Robin1,2,3, Aude Lessene4, Igor Lacombat5, Laurent Dortet6,7,8, Thierry Naas6,7,8, Valérie Ponties9, Richard Bonnet10,2,3.   

Abstract

The spread of mcr-1-encoding plasmids into carbapenem-resistant Enterobacteriaceae raises concerns about the emergence of untreatable bacteria. We report the acquisition of mcr-1 in a carbapenem-resistant Escherichia coli strain after a 3-week course of colistin in a patient repatriated to France from Portugal. Whole-genome sequencing revealed that the Klebsiella pneumoniae carbapenemase-producing E. coli strain acquired two plasmids, an IncL OXA-48-encoding plasmid and an IncX4 mcr-1-encoding plasmid. This is the first report of mcr-1 in carbapenemase-encoding bacteria in France.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Escherichia coli; KPC-28; KPC-3; OXA-48; antibiotic resistance; carbapenemase; colistin; mcr-1; β-lactamases

Mesh：

Substances：

Year:  2017        PMID： 28507112      PMCID： PMC5527634          DOI： 10.1128/AAC.02540-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Genetic features of the widespread plasmid coding for the carbapenemase OXA-48.

Authors:  Laurent Poirel; Rémy A Bonnin; Patrice Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

2.  Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli.

Authors:  Laurent Poirel; Nicolas Kieffer; Nadia Liassine; Dang Thanh; Patrice Nordmann
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

3.  Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany.

Authors:  Linda Falgenhauer; Said-Elias Waezsada; Yancheng Yao; Can Imirzalioglu; Annemarie Käsbohrer; Uwe Roesler; Geovana Brenner Michael; Stefan Schwarz; Guido Werner; Lothar Kreienbrock; Trinad Chakraborty
Journal:  Lancet Infect Dis       Date:  2016-01-08       Impact factor: 25.071

4.  Assembling single-cell genomes and mini-metagenomes from chimeric MDA products.

Authors:  Sergey Nurk; Anton Bankevich; Dmitry Antipov; Alexey A Gurevich; Anton Korobeynikov; Alla Lapidus; Andrey D Prjibelski; Alexey Pyshkin; Alexander Sirotkin; Yakov Sirotkin; Ramunas Stepanauskas; Scott R Clingenpeel; Tanja Woyke; Jeffrey S McLean; Roger Lasken; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2013-10       Impact factor: 1.479

5.  IS1R-mediated plasticity of IncL/M plasmids leads to the insertion of bla OXA-48 into the Escherichia coli Chromosome.

Authors:  R Beyrouthy; F Robin; J Delmas; L Gibold; G Dalmasso; F Dabboussi; M Hamzé; R Bonnet
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

6.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

Authors:  Yi-Yun Liu; Yang Wang; Timothy R Walsh; Ling-Xian Yi; Rong Zhang; James Spencer; Yohei Doi; Guobao Tian; Baolei Dong; Xianhui Huang; Lin-Feng Yu; Danxia Gu; Hongwei Ren; Xiaojie Chen; Luchao Lv; Dandan He; Hongwei Zhou; Zisen Liang; Jian-Hua Liu; Jianzhong Shen
Journal:  Lancet Infect Dis       Date:  2015-11-19       Impact factor: 25.071

7.  The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups.

Authors:  Olivier Clermont; Julia K Christenson; Erick Denamur; David M Gordon
Journal:  Environ Microbiol Rep       Date:  2012-12-24       Impact factor: 3.541

8.  Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015.

Authors:  Henrik Hasman; Anette M Hammerum; Frank Hansen; Rene S Hendriksen; Bente Olesen; Yvonne Agersø; Ea Zankari; Pimlapas Leekitcharoenphon; Marc Stegger; Rolf S Kaas; Lina M Cavaco; Dennis S Hansen; Frank M Aarestrup; Robert L Skov
Journal:  Euro Surveill       Date:  2015

9.  Detection of the mcr-1 Colistin Resistance Gene in Carbapenem-Resistant Enterobacteriaceae from Different Hospitals in China.

Authors:  Hua Yu; Fen Qu; Bin Shan; Bin Huang; Wei Jia; Cha Chen; Aiqing Li; Minhui Miao; Xin Zhang; Chunmei Bao; Yunmin Xu; Kalyan D Chavda; Yi-Wei Tang; Barry N Kreiswirth; Hong Du; Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

10.  Pilon: an integrated tool for comprehensive microbial variant detection and genome assembly improvement.

Authors:  Bruce J Walker; Thomas Abeel; Terrance Shea; Margaret Priest; Amr Abouelliel; Sharadha Sakthikumar; Christina A Cuomo; Qiandong Zeng; Jennifer Wortman; Sarah K Young; Ashlee M Earl
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240
View more
  21 in total

1.  Evaluation of the Amplidiag CarbaR+MCR Kit for Accurate Detection of Carbapenemase-Producing and Colistin-Resistant Bacteria.

Authors:  Delphine Girlich; Sandrine Bernabeu; Victor Grosperrin; Isabelle Langlois; Christine Begasse; Nicolas Arangia; Elodie Creton; Garance Cotellon; Aimie Sauvadet; Laurent Dortet; Thierry Naas
Journal:  J Clin Microbiol       Date:  2019-02-27       Impact factor: 5.948

Review 2.  The rise and spread of mcr plasmid-mediated polymyxin resistance.

Authors:  Sue C Nang; Jian Li; Tony Velkov
Journal:  Crit Rev Microbiol       Date:  2019-05-23       Impact factor: 7.624

3.  CTX-M-55-, MCR-1-, and FosA-Producing Multidrug-Resistant Escherichia coli Infection in a Child in France.

Authors:  André Birgy; Fouad Madhi; Julien Hogan; Catherine Doit; Jean Gaschignard; Marion Caseris; Philippe Bidet; Robert Cohen; Stéphane Bonacorsi
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 4.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

5.  Comparison of the Superpolymyxin and ChromID Colistin R Screening Media for the Detection of Colistin-Resistant Enterobacteriaceae from Spiked Rectal Swabs.

Authors:  Delphine Girlich; Thierry Naas; Laurent Dortet
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

6.  Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China.

Authors:  Changfu Yin; Weiwei Yang; Yuanpeng Lv; Peng Zhao; Jiansheng Wang
Journal:  BMC Microbiol       Date:  2022-03-29       Impact factor: 3.605

7.  Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.

Authors:  R Christopher D Furniss; Nikol Kaderabkova; Declan Barker; Patricia Bernal; Evgenia Maslova; Amanda A A Antwi; Helen E McNeil; Hannah L Pugh; Laurent Dortet; Jessica M A Blair; Gerald Larrouy-Maumus; Ronan R McCarthy; Diego Gonzalez; Despoina A I Mavridou
Journal:  Elife       Date:  2022-01-13       Impact factor: 8.713

8.  In Vitro Activity of Ceftazidime-Avibactam and Aztreonam-Avibactam against OXA-48-Carrying Enterobacteriaceae Isolated as Part of the International Network for Optimal Resistance Monitoring (INFORM) Global Surveillance Program from 2012 to 2015.

Authors:  Krystyna M Kazmierczak; Patricia A Bradford; Gregory G Stone; Boudewijn L M de Jonge; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

9.  Multicenter prospective study on the prevalence of colistin resistance in Escherichia coli: relevance of mcr-1-positive clinical isolates in Lombardy, Northern Italy.

Authors:  Luigi Principe; Aurora Piazza; Carola Mauri; Adriano Anesi; Silvia Bracco; Gioconda Brigante; Erminia Casari; Carlo Agrappi; Mariasofia Caltagirone; Federica Novazzi; Roberta Migliavacca; Laura Pagani; Francesco Luzzaro
Journal:  Infect Drug Resist       Date:  2018-03-09       Impact factor: 4.003

10.  Optimal Empiric Polymyxin B Treatment of Patients Infected with Gram-Negative Organisms Detected Using a Blood Antimicrobial Surveillance Network in China.

Authors:  Xingbing Wu; Chen Huang; Hui Wang; Jinru Ji; Chaoqun Ying; Yonghong Xiao
Journal:  Drug Des Devel Ther       Date:  2021-06-17       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.